Citalopram: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
WanaraLima (bicara | kontrib)
Artikel baru tentang topik farmasi yang masih memerlukan tambahan dan pengembangan. Artikel ini merupakan terjemahan wikipedia bahasa Inggris masih perlu ditinjau ulang juga disesuaikan dengan padanan bahasa Indonesia
Tag: halaman dengan galat kutipan VisualEditor
Tag: halaman dengan galat kutipan
 
(8 revisi perantara oleh 4 pengguna tidak ditampilkan)
Baris 73:
}}
 
'''Citalopram''' adalah obat untuk mengatasi [[antidepresan]] golongan Selective Serotonin Reuptake Inhibitor (SSRI). <ref name="AHFS2018">{{Cite web|title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live |access-date=23 December 2018}}</ref> Obat ini digunakan untuk mengatasi [[gangguan depresi mayor]], [[gangguan obsesif kompulsif]], gangguan panik, dan [[Gangguan kecemasan sosial|fobia sosial]] . <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref> Untuk mendapatkan efek terapi antidepresan diperlukan waktu satu hingga empat minggu. <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref> Rute pemberian obat melalui oral. <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref>
 
Kejadian efek samping obat yang umum pada obat ini seperti rasa mual, insomnia, masalah seksual, gemetar, merasa lelah, dan berkeringat. <ref name="AHFS2018">{{Cite web|title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live |access-date=23 December 2018}}<cite class="citation web cs1" data-ve-ignore="true">[https://www.drugs.com/monograph/citalopram-hydrobromide.html "Citalopram Hydrobromide Monograph for Professionals"]. ''Drugs.com''. AHFS. [https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html Archived] from the original on 23 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite></ref> Kejadian efek samping yang serius yakni potensi risiko [[bunuh diri]] jika digunakan pada individu usia di bawah 25 tahun, [[sindrom serotonin]], [[glaukoma]], dan [[Sindrom QT panjang|perpanjangan interval QT]] . <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref> Obat Ini tidak direkomendasikan untuk digunakan bersama golongan inhibitor MAO . <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref> Sindrom penghentian antidepresan dapat terjadi ketika dihentikan. <ref name="AHFS2018">{{cite web |title=Citalopram Hydrobromide Monograph for Professionals |url=https://www.drugs.com/monograph/citalopram-hydrobromide.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=23 December 2018 |archive-url=https://web.archive.org/web/20181223073739/https://www.drugs.com/monograph/citalopram-hydrobromide.html |url-status=live }}</ref> Penggunaan obat ini pada ibu hamil berpotensi membahayakan bayi. <ref>{{Cite web|title=Citalopram (Celexa) Use During Pregnancy|url=https://www.drugs.com/pregnancy/citalopram.html|website=Drugs.com|archive-url=https://web.archive.org/web/20181223073744/https://www.drugs.com/pregnancy/citalopram.html|archive-date=23 December 2018|access-date=23 December 2018|url-status=live}}</ref>
 
== Referensi ==
 
[[Kategori:Obat yang dikembangkan oleh AbbVie]]
[[Kategori:FarmasiAntidepresan]]
[[Kategori:Benzonitril]]
[[Kategori:Penghambat CYP2D6]]
[[Kategori:Senyawa dimetilamino]]
[[Kategori:Senyawa 4-fluorofenil]]
[[Kategori:Isobenzofuran]]
[[Kategori:Penghambat pengambilan kembali serotonin selektif]]
[[Kategori:Agonis sigma]]
<references />{{Farmasi-stub}}